The A's Have It: Developing Apolipoprotein A-I Mimetic Peptides Into a Novel Treatment for Asthma. [PDF]
Chest, 2016 Yao X +4 more
europepmc +1 more source
Molecular Dynamics Simulations of Apolipoprotein A-I Peptide Mimetic 4F [PDF]
Biophysical Journal, 2009 openaire +1 more source
Artificial recombinant high-density protein nanocarriers for precision drug delivery. [PDF]
Chem SciLi W, Jia N, Li M, Jiang Y, Lu J.
europepmc +1 more source
Bioactive peptides targeting dyslipidemia and atherosclerosis: from computational discovery and data bottlenecks to precision medicine translation. [PDF]
Front Mol BiosciYin W, Wang Q, Zeng Z, Xie X.
europepmc +1 more source
Apolipoprotein A-I (CSL112) and Cardiovascular Outcomes in Atherosclerotic Cardiovascular Disease: A Scoping Review. [PDF]
Clin CardiolHabib A +6 more
europepmc +1 more source
ApoE COG 133 mimetic peptide improves survival, infection burden, and <i>Clostridioides difficile</i> toxin-A-induced intestinal damage in mice. [PDF]
Exp Biol Med (Maywood)de Azevedo OGR +8 more
europepmc +1 more source
Apolipoprotein A-I mimetic peptides inhibit expression and activity of hypoxia-inducible factor-1α in human ovarian cancer cell lines and a mouse ovarian cancer model. [PDF]
J Pharmacol Exp Ther, 2012 Gao F +7 more
europepmc +1 more source
Apolipoprotein A-I mimetic peptides in dyslipidemia and atherosclerosis: an investigational timeline
Clinical Lipidology, 2015 openaire +1 more source
α-Helical peptides: design strategies and recent advances in biomedical applications. [PDF]
J Transl MedYin M, Ding F, Luo G, Yu M.
europepmc +1 more source
Therapeutic Potential of the ApoE-Mimicked Peptide COG133: Regulation of miRNA146‑a in Diabetic Fibroblasts and Antibacterial Activity. [PDF]
ACS OmegaAk A +5 more
europepmc +1 more source